ECRI Institute launches digital resource for coronavirus
The ECRI Institute recently launched its Coronavirus Outbreak Preparedness Center for healthcare providers and hospitals to learn how to protect themselves and their patients.…
News
Summary of updates to guidelines for managing severe TBI in children
The American Journal of Critical Care has published an article that highlights the most important updates featured in the third edition of the guidelines…
New treatment for peanut allergy in children
The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for children suffering from peanut allergy. (more…)
Top heart health apps for nurses
To acknowledge American Heart Month, American Nurse would like to highlight some of the best heart health apps, including some providers can use in…
FDA launches mobile app on antiretrovirals
On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase under the…
New report puts coronavirus infection count over 75K in Wuhan
A new report indicates that there could be over 75,000 reports of coronavirus infections in Wuhan, China, and almost 10,000 cases across the entire…
Study examines link between gut health and Parkinson’s
A new study examines the connection between gut health and Parkinson’s Disease (PD). The study explores the idea of gut-brain health, which has become…
New treatment for advanced epithelioid sarcoma
The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with metastatic or…
Survey reveals 40% of patients with MS stop taking medications because of cost
A new survey conducted by the National MS Society (NMSS) reveals that 40% of respondents “altered or stopped taking their [MS-associated] medication” due to…
Study highlights increases in amount of out-of-pocket spending for maternity care
A recent study published in Health Affairs highlights how much the out-of-pocket (OOP) expenses for maternity care have increased over time. (more…)
First FDA approved treatment for thyroid eye disease
The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults with thyroid…
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)
ECRI Institute launches digital resource for coronavirus
The ECRI Institute recently launched its Coronavirus Outbreak Preparedness Center for healthcare providers and hospitals to learn how to protect themselves and…
Summary of updates to guidelines for managing severe TBI in children
The American Journal of Critical Care has published an article that highlights the most important updates featured in the third edition of…
New treatment for peanut allergy in children
The U.S. Food and Drug Administration (FDA) recently approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] for children suffering from peanut…
Top heart health apps for nurses
To acknowledge American Heart Month, American Nurse would like to highlight some of the best heart health apps, including some providers can…
FDA launches mobile app on antiretrovirals
On Jan. 29, the FDA launched an interactive database that will offer a wealth of critical information about antiretrovirals eligible for purchase…
New report puts coronavirus infection count over 75K in Wuhan
A new report indicates that there could be over 75,000 reports of coronavirus infections in Wuhan, China, and almost 10,000 cases across…
Study examines link between gut health and Parkinson’s
A new study examines the connection between gut health and Parkinson’s Disease (PD). The study explores the idea of gut-brain health, which…
New treatment for advanced epithelioid sarcoma
The U.S. Food and Drug Administration (FDA) recently approved Epizyme, Inc’s tazemetostat (TAZVERIK) for the treatment of adult and pediatric patients with…
Survey reveals 40% of patients with MS stop taking medications because of cost
A new survey conducted by the National MS Society (NMSS) reveals that 40% of respondents “altered or stopped taking their [MS-associated] medication”…
Study highlights increases in amount of out-of-pocket spending for maternity care
A recent study published in Health Affairs highlights how much the out-of-pocket (OOP) expenses for maternity care have increased over time. (more…)
First FDA approved treatment for thyroid eye disease
The U.S. Food and Drug Administration (FDA) recently approved Horizon Therapeutics Ireland DAC’s teprotumumab-trbw (Tepezza) as the first FDA-approved treatment for adults…
Making diabetes education more effective
Is individual or group education most effective for patients with diabetes? (more…)